New Executive Takes the Helm at AccentCare

 

By Holly Vossel

Dr. Balu Natarajan has become AccentCare’s new executive vice president and chief medical officer.

Natarajan’s role expanded after previously serving as the post-acute company’s chief medical officer for hospice since 2005. In addition to oversee AccentCare’s hospice and palliative care programs, he will also support its clinical care operations and patient experience initiatives.

Prior to joining AccentCare, Natarajan founded Chicago Primary Care Sports Medicine. He also currently serves as president of the North South Foundation.

“In his almost two decades with our company, Dr. Natarajan has been an invaluable asset to our team, demonstrating exceptional leadership and medical expertise,” AccentCare CEO Laura Tortorella said in a statement. “With his proven track record of putting patients first and building best-in-class clinical teams, I am confident that Dr. Natarajan will continue to advance our delivery of high-quality, consistent and connected care.”

The news follows another executive shift in January when the company tapped a new CFO, Saurabh Gupta. Tortorella joined AccentCare as CEO last September.

AccentCare is a portfolio company of the private equity firm Advent International, which purchased the provider from Oak Hill Capital Partners in 2019 for an undisclosed sum. The company merged with Illinois-based Seasons Hospice & Palliative Care in 2020.

AccentCare provides hospice, palliative and personal care, along with home health, non-medical services, care management and high-acuity home care. The Dallas-headquartered company operates upwards of 250 locations in 32 states and in the District of Columbia and has an annual census of more than 200,000 patients.

“Our team will continue to be guided by the patient’s voice and put patients at the center of everything we do as we deliver high-quality care,” Natarajan said. “From coast to coast, patients and their families are counting on providers to help them navigate a complex health care system. I look forward to working with our clinical teams and partners to develop and implement strategies that promote innovation and drive successful patient experiences and outcomes.”